LUCA Science
PrivateLast Round
Series B
Jun 6, 2022
Total Funding Raised
$40.1M
Company Overview
LUCA Science operates in Healthcare & Life Sciences and is based in Tokyo. Its latest recorded funding round was a Series B round in June 2022.
LUCA Science is a biotechnology company that develops functional mitochondria as therapeutic agents to treat damaged tissues and organs by enhancing and stabilizing mitochondrial activity.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
LUCA Science Comparables
Compare LUCA Science with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| cellvie | 81% | |
| PAEAN Biotechnology | 81% | |
| Astellas Pharma Inc. | 81% |
For institutional investors. Book with your work email.
LUCA Science Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jun 6, 2022 | ||||
| Series A | Aug 31, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
LUCA Science Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Daiwa Securities Group | Series B |
| Shinsei Capital Partners | Series B |
| DCI Partners | Series B |
| 日本ベンチャーキャピタル株式会社 | Series B, Series A |
| Remiges Ventures | Series B, Series A |
| 4BIO Capital | Series B |
| Nissay Capital | Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 31, 2020
$10M round led by Axil Capital
For institutional investors. Book with your work email.
LUCA Science Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about LUCA Science's valuation, stock price, and market status.
Is LUCA Science a public or private company?
LUCA Science is a private company.
What is the current stock price of LUCA Science?
LUCA Science is a private company, so its shares have no public market price. Caplight tracks LUCA Science's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is LUCA Science worth (valuation)?
Valuation information for LUCA Science is not publicly available.
Can I buy LUCA Science stock?
LUCA Science shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was LUCA Science's last funding round?
LUCA Science's most recent funding round was Series B on June 6, 2022.
Who are the main investors in LUCA Science?
Key investors in LUCA Science include DCI Partners, 4BIO Capital, Axil Capital Partners, Axil Capital, Fast Track Initiative.
Will LUCA Science IPO soon?
No public IPO plans have been announced for LUCA Science.
How can I track LUCA Science secondary market activity?
Caplight tracks bids, offers, and trades in LUCA Science's shares on secondary markets.